Clinical trial
Study Of Indiplon/Placebo With Sertraline In Insomnia Co-Existing With…
NCT00232167 · Neurocrine Biosciences, Industry · Terminated
Key facts
| NCT number | NCT00232167 |
|---|---|
| Title | Study Of Indiplon/Placebo With Sertraline In Insomnia Co-Existing With Depression |
| Official title | Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy And Tolerability Of Indiplon Therapy Initiated With Sertraline Versus Sertraline Monotherapy In Subjects With Insomnia And Co-Existing Major Depressive Disorder |
| Lead sponsor | Neurocrine Biosciences, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Insomnia, Depression |
| Intervention type | Drug |
| Interventions | Indiplon, Sertraline |
| Enrollment | 380 |
| Start date | Nov 1, 2005 |
| Completion | Apr 1, 2006 |
| First posted | Oct 4, 2005 |
| Last update posted | Oct 2, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: